It is important that treatment follows the recommended intervals. If these intervals cannot he upheld, for example due to neutropenia, bone marrow stimulating growth factor (G-CSF) can stimulate the bone marrow to reach an acceptable level before each planned course of chemotherapy.
Surgery is rarely indicated for Hodgkin's lymphoma.
Curing the disease is still possible after recurrence, and in some cases, after later recurrences. The prognosis of patients with recurrence is better if the relapse develops late after completion of the primary treatment. If recurrence occurs outside the radiation field where radiotherapy was the only primary treatment modality, the prognosis is almost as good as at the time of diagnosis. It is important that the role of radiation therapy in treatment of recurrence is evaluated before chemotherapy begins.
Responsibility for treatment of Hodgkin's lymphoma is centralized to the university hospitals.